In the pancreas, STAT3 is dispensable for normal development, however, in the majority of PC a constitutive STAT3 activation due to phosphorylation of Tyr705 can be found (191–193), suggesting STAT3 as a potential therapeutic target in PC. The gene discussed is STAT3; the disease is pachyonychia congenita.